Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions
The Centers for Disease Control recommends pneumococcal vaccination for U.S. adults aged 19–64 years with chronic or immunocompromising conditions, however, vaccination coverage is low and regional variations in coverage are rarely studied. This study examined pneumococcal vaccination coverage at th...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-01-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2023.2194779 |
| _version_ | 1797673075895959552 |
|---|---|
| author | Junqing Liu Linda Shoener Dunham Kelly D. Johnson |
| author_facet | Junqing Liu Linda Shoener Dunham Kelly D. Johnson |
| author_sort | Junqing Liu |
| collection | DOAJ |
| description | The Centers for Disease Control recommends pneumococcal vaccination for U.S. adults aged 19–64 years with chronic or immunocompromising conditions, however, vaccination coverage is low and regional variations in coverage are rarely studied. This study examined pneumococcal vaccination coverage at the metropolitan statistical area (MSAs) level and identified regional factors associated with pneumococcal vaccination using the combined IBM® Watson Health MarketScan® Commercial and Medicare Supplemental databases. Pneumococcal vaccination coverage, clinical and socioeconomic factors were calculated for each MSA. Ordinary least square and spatial regression models were used to examine factors associated with vaccination. Results indicated that the national pneumococcal vaccination coverage was 13.4% with a large variation across MSAs (0–34%). The spatial error model, model with the best fit, showed that proportions of the population who were ≥50 years of age, received an influenza vaccine, or had health maintenance organization health plans were positively associated with pneumococcal vaccination coverage. In summary, we found that national pneumococcal vaccination coverage was low and there was substantial variation across MSAs. Regional factors identified may help inform interventions to improve pneumococcal vaccination coverage across geographies. |
| first_indexed | 2024-03-11T21:40:15Z |
| format | Article |
| id | doaj.art-f1a1155a75b640faac6e31b3831c5674 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:40:15Z |
| publishDate | 2023-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-f1a1155a75b640faac6e31b3831c56742023-09-26T13:25:49ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-01-0119110.1080/21645515.2023.21947792194779Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditionsJunqing Liu0Linda Shoener Dunham1Kelly D. Johnson2Merck & Co., IncMerck & Co., IncMerck & Co., IncThe Centers for Disease Control recommends pneumococcal vaccination for U.S. adults aged 19–64 years with chronic or immunocompromising conditions, however, vaccination coverage is low and regional variations in coverage are rarely studied. This study examined pneumococcal vaccination coverage at the metropolitan statistical area (MSAs) level and identified regional factors associated with pneumococcal vaccination using the combined IBM® Watson Health MarketScan® Commercial and Medicare Supplemental databases. Pneumococcal vaccination coverage, clinical and socioeconomic factors were calculated for each MSA. Ordinary least square and spatial regression models were used to examine factors associated with vaccination. Results indicated that the national pneumococcal vaccination coverage was 13.4% with a large variation across MSAs (0–34%). The spatial error model, model with the best fit, showed that proportions of the population who were ≥50 years of age, received an influenza vaccine, or had health maintenance organization health plans were positively associated with pneumococcal vaccination coverage. In summary, we found that national pneumococcal vaccination coverage was low and there was substantial variation across MSAs. Regional factors identified may help inform interventions to improve pneumococcal vaccination coverage across geographies.http://dx.doi.org/10.1080/21645515.2023.2194779pneumococcal vaccination coverageadultsspatial modelingregional variationunited statesmetropolitan statistical area |
| spellingShingle | Junqing Liu Linda Shoener Dunham Kelly D. Johnson Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions Human Vaccines & Immunotherapeutics pneumococcal vaccination coverage adults spatial modeling regional variation united states metropolitan statistical area |
| title | Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions |
| title_full | Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions |
| title_fullStr | Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions |
| title_full_unstemmed | Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions |
| title_short | Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions |
| title_sort | regional factors associated with pneumococcal vaccination coverage among u s adults with underlying chronic or immunocompromising conditions |
| topic | pneumococcal vaccination coverage adults spatial modeling regional variation united states metropolitan statistical area |
| url | http://dx.doi.org/10.1080/21645515.2023.2194779 |
| work_keys_str_mv | AT junqingliu regionalfactorsassociatedwithpneumococcalvaccinationcoverageamongusadultswithunderlyingchronicorimmunocompromisingconditions AT lindashoenerdunham regionalfactorsassociatedwithpneumococcalvaccinationcoverageamongusadultswithunderlyingchronicorimmunocompromisingconditions AT kellydjohnson regionalfactorsassociatedwithpneumococcalvaccinationcoverageamongusadultswithunderlyingchronicorimmunocompromisingconditions |